SHANGHAI, Feb. 10, 2026 /PRNewswire/ -- AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning the full ...
SPRINGFIELD — State agencies focused on science and jobs have awarded Western New England University a total of $1.3 million in three recent grants: one in biopharmaceutical technology, one in ...
FREMONT, Calif., Feb. 20, 2025 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of its Certified ...
Cell and gene therapy has made biopharmaceutical R&D spaces more valuable, increasing the demand for stricter quality control measures to maintain optimal environments. Avid Bioservices has been ...
No articles found. Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd. did not contribute to any primary research papers from Nature Index journals in the current 12 month window.
23d
Empowered by Pipeline and Forged by Technology: Mabwell Successfully Lists on the Main Board of HKEX
Driven by the continuous innovation in global biopharmaceutical technology, the steady rollout of favorable policies, and escalating clinical demands, the biopharmaceutical ...
Huawu Biopharmaceutical Technology (Hubei) Co. Ltd. has divulged new viral replication inhibitors potentially useful for the treatment of dengue and yellow fever virus infections.
The biopharmaceutical field leads the way in science, researching and developing new treatments for health needs. In 2024, research and development in this area will face fast changes, bringing both ...
HONG KONG, Feb. 10, 2026 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technologies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results